Clinical Trials Logo

Clinical Trial Summary

Building upon existing evidence on loneliness and pain research, conversational voice assistant (CVA)technology and personalized persuasion, we have assembled an interdisciplinary and inter-institutional team of researchers to conduct a 12-week randomized control pilot with older adults that live alone and self-report pain. Participants will interact with a standard or a personally enhanced loneliness routine delivered through a CVA. We will explore intervention feasibility and examine the efficacy of both standard and personalized interventions on loneliness and secondary outcomes. Inclusion: 1) men and women 60 years of age; 2) live alone (single-family home, independent, or assisted living); 3) self-report have experienced or currently experiencing musculoskeletal pain; and 4) wireless internet access via a broadband Internet connection. Exclusion: 1) memory loss as evidenced by poor performance on the Mini Cog; 2) inability to speak English; 3) prior study participation; 4) prior use or current use of a conversational voice assistant; and 5) not willing to engage with the voice assistant. Our proposed study is comprised of 1) a one week pre-study session for participant equipment set-up, training, and baseline pre- study data collection; 2) a 12-week randomized trial of the standard or the enhanced CVA delivered interventions; and 3) a one-week post-study data collection.


Clinical Trial Description

.We propose to conduct a 12-week pilot randomized controlled trial. Participants will be randomly assigned with equal distribution to the conversational voice assistant-standard group (CVA-S, n=30) or the conversational voice assistant-enhanced loneliness routine treatment group (CVA-ELR, n=30). Data will be collected at pre (baseline) and post intervention (after 12-weeks). The 12-week duration was chosen based on published intervention studies designed to reduce loneliness in older adults.20 Both groups will receive basic training on how to use the conversational voice assistant. Study Groups Group 1. Conversational Voice Assistant Standard Loneliness Routine (CVA-S) Participants in the CVA-S group will receive an a priori set of evidence-based interactions to perform with the conversational voice assistant. The interaction dose will be 15 minutes performed once in the morning and once in the evening, at pre-set times. The participants will 1) do a meditation activity, 2) play an interactive trivia game, and 3) ask the assistant to tell a joke. These activities were selected based on prior literature; programs involving meditation and humor therapy have been found to reduce loneliness, and humor therapy has also been found to relieve pain.25,26 Activities that encourage productive engagement have been found to help reduce social isolation and loneliness6, particularly those involving challenge.27 Group 2. Conversational Voice Assistant Enhanced Loneliness Routine (CVA-ELR) Participants in the CVA-ELR group will receive personalized intervention materials based on individual baseline personality and entertainment inventory results. Potential personalization tactics used to match intervention materials with each individual's personality and entertainment preferences include: identification (name integration), expectation (customization claim), contextualization (meaningful personal context), descriptive (personal data), comparative (contrast to others), evaluative (personal recommendation).28 The CVA-S and personalized CVA-ELR interventions will use the minimum viable user experience (UX) design approach to develop intervention materials and will be delivered through a smart speaker. 5,24,29 Participants: This study will include N=65 participants. Inclusion criteria include: 1) men and women≥60 years of age; 2) live alone (single-family home, independent, or assisted living); 3) have experienced or currently experiencing musculoskeletal pain; and 4) wireless internet access via a broadband Internet connection. Exclusion criteria include: 1) memory loss as evidenced by poor performance on the Mini Cog; 2) inability to speak English; 3) prior use or current use of a conversational voice assistant; and 4) not willing to engage with the voice assistant. Recruitment: We will use two main strategies for recruiting participants: 1) direct referral from those with ethical access in clinics and independent or assisted living facilities and 2) community and social media marketing. Variables and Instruments Sample Characteristics Demographics, Health History and Social Support: Investigator developed questionnaires will be used to collect self-reported descriptive demographic and health history. Aim 1. Examine the feasibility of using voice assistant technology to conduct a 12-week study with standard (CVA-S) and enhanced loneliness routine voice assistant (CVA-ELR) interactions among aging adults that live alone. Outcomes Objective Use: We will securely access the participants' voice assistant profiles and document the time stamps of intervention activities to assess frequency and length of use, type of uses, and routine completion rates with the standard and enhanced loneliness routines.24 Usability: Usability will be measured using the System Usability Scale. The 10 question 5-point Likert scale scores range from 0-100 and scores above 68 are above average.30 Satisfaction: Short-term and long-term satisfaction will be measured with one question from the Customer Satisfaction (CST) and one question from the Net Promotor Score (NPS). The CST question "How would you rate the overall satisfaction with the program you received?" has a 1 to 5 scale response ranging from very unsatisfied to very satisfied. The NPS question "How likely is it that you would recommend the program to a friend or colleague?" has a scale from 1-10 with responses ranging very unlikely to very likely.31 A score of 7 or higher for CST or NPS indicates satisfaction of the intervention technology.32 A minimum coefficient alpha of .70 will be adopted for all usability outcome measures adhering to the minimum reliability standard in evaluation research.33 The minimum viable UX in both standard and enhanced conditions will produce satisfactory user comprehension of the intervention's key functionalities. Aim 2. Evaluate the efficacy of standard (CVA-S) and enhanced loneliness routine voice assistant (CVA-ELR) interactions among aging adults that live alone. Outcomes Loneliness: Subjective social isolation and loneliness will be measured using the University of California Los Angeles, UCLA Loneliness Scale Version 3, a 20-item instrument with responses of never, rarely, sometimes, and always. There is no standard accepted score for identifying loneliness; higher scores reflect greater reported loneliness. The scale has established validity and reliability with Cronbach's alphas ranging from 0.85 to 0.94.34 Pain Severity and Pain Interference: Subjective pain will be measured using the Brief Pain Inventory Short form (BPI-SF).The instrument has nine questions that measure pain severity and pain interference with function. The severity questions assess pain numerically ranging from 0 no pain to 10 pain as bad as you can imagine; interference questions assess interference from 0 no interference to 10 completely interferes. Higher scores indicate higher severity or interference with 0 being none, 1-3 mild, 4-6 moderate, 7-10 severe. The BPI-SF has Cronbach alphas ranging from 0.86-0.96.35 Data Analysis Aim #1: We will obtain descriptive statistics of the objective use data. We will use the mean score for each usability or satisfaction outcome to perform independent samples T-tests to compare the sample mean score with the critical cut off scores. Aim #2: We will calculate mean and standard deviations on the UCLA Loneliness Scale and BPI-SF scores at baseline and after the 12-week intervention. We will compare the average questionnaire scores within and between the CVA-S and CVA-ELR groups using paired T-tests and multiple linear regression. The analysis will be run for the two outcomes separately. A minimum sample of 59 participants was calculated at 80% power, 0.35 effect size, and 0.05 significance. The proposed sample size accounts for a 10% study attrition. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05387447
Study type Interventional
Source University of Nebraska
Contact Marcia Y Shade, PhD, RN
Phone 402-559-6641
Email marcia.shade@unmc.edu
Status Recruiting
Phase N/A
Start date March 1, 2022
Completion date June 30, 2024

See also
  Status Clinical Trial Phase
Completed NCT05452499 - Pain Neuroscience Education and Therapeutic Exercise as a Treatment for Breast Cancer Survivors Living With Sequelae N/A
Recruiting NCT05037682 - Pain and Opioid Management in Older Adults N/A
Completed NCT04080037 - Assessing Opioid Care Practices Using CPV Patient Simulation Modules N/A
Recruiting NCT05382962 - iCanCope With Post-Operative Pain (iCanCope PostOp) N/A
Recruiting NCT04285112 - SPRINT: Signature for Pain Recovery IN Teens
Active, not recruiting NCT04850079 - EHR Precision Drug Treatment in Neonates
Completed NCT03271151 - Effect of Duloxetine on Opioid Use After Total Knee Arthroplasty Phase 4
Completed NCT03272139 - Interscalene Block Versus Superior Trunk Block Phase 4
Completed NCT03886142 - Platelet Rich Plasma Versus Radio Frequency for Chronic Knee Arthritis N/A
Recruiting NCT05761392 - APP-based Precise Management System of Chronic Intractable Pain N/A
Recruiting NCT05877157 - Pain AND Opioids After Surgery
Completed NCT03947749 - Linking Epigenomics With Prescription Opioid Abuse and High Impact Musculoskeletal Pain
Completed NCT03280017 - Ketamine With Multilevel Paravertebral Block for Post Video-assisted Thoracic Surgery Pain Phase 4
Recruiting NCT04874038 - Prevention of Persistent Pain With LidocAine iNfusions in Breast Cancer Surgery (PLAN) Phase 3
Completed NCT04280796 - Changes in Affective Pain Processing in Human Volunteers N/A
Withdrawn NCT05125978 - Efficacy and Safety of Canadá Association in the Treatment of Chronic Pain Phase 2
Not yet recruiting NCT04328805 - Pain Reduction and Changes in Upper Limb Function Produced by an Ibuprofen Treatment in Carpal Tunnel Syndrome. Phase 4
Completed NCT04976738 - A Study of Cybis™ 10:25 THC:CBD Oil in Adults With Chronic Back/Neck Pain Phase 1/Phase 2
Completed NCT04089618 - Meditation Based Lifestyle Modification in Chronic Pain N/A
Recruiting NCT05699837 - Alpha Entrainment for Pain and Sleep (Extension) N/A